Fei Chu
Impact in
- Geriatrics and Gerontology top 5%
- Sirtuins and Resveratrol in Medicine
- Oncology top 10%
- HER2/EGFR in Cancer Research
- Cancer-related Molecular Pathways
Papers in
-
- Histone Deacetylase Inhibitors Research 5
- Cell death mechanisms and regulation 5
- Protein Degradation and Inhibitors 2
-
- Neuroblastoma Research and Treatments 8
- Co-authors
- Abdelhadi Rebbaa (8 shared papers)Bernard L. Mirkin (7 shared papers)Xin Zheng (5 shared papers)Radhika Gudi (3 shared papers)John Barkinge (3 shared papers)Pauline M. Chou (4 shared papers)Prasad Kanteti (1 shared paper)Ravi Salgia (1 shared paper)
- Journals
- Journal of Pediatric Surgery (3 papers)Cancer Research (3 papers)Journal of the American College of Surgeons (2 papers)Oncogene (2 papers)Angiogenesis (1 paper)
- Partner nations
- United StatesChinaTaiwan
In The Last Decade
Fei Chu
33 papers receiving 1.1k citations
Peers
Comparison fields: 5 of 85
- Geriatrics and Gerontology 101
- Oncology 381
- Cancer Research 181
- Molecular Biology 574
- Cell Biology 104
Countries citing papers authored by Fei Chu
This map shows the geographic impact of Fei Chu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fei Chu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fei Chu more than expected).
Fields of papers citing papers by Fei Chu
This network shows the impact of papers produced by Fei Chu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fei Chu. The network helps show where Fei Chu may publish in the future.
Co-authors
The 25 scholars most cited alongside Fei Chu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 34 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2005 | 198 | |
| 2 | 2005 | 142 | |
| 3 | 2017 | 75 | |
| 4 | 2002 | 68 | |
| 5 | 2005 | 59 | |
| 6 | 2008 | 50 | |
| 7 | 2006 | 48 | |
| 8 | 2008 | 47 | |
| 9 | 2008 | 43 | |
| 10 | 2022 | 41 | |
| 11 | 2016 | 41 | |
| 12 | 2004 | 39 | |
| 13 | 2013 | 33 | |
| 14 | 2006 | 30 | |
| 15 | 2014 | 29 | |
| 16 | 2022 | 19 | |
| 17 | 2014 | 15 | |
| 18 | 2012 | 13 | |
| 19 | 2012 | 12 | |
| 20 | 1995 | 12 |
About Fei Chu
Fei Chu is a scholar working on Molecular Biology, Neurology, Oncology, Epidemiology and Cell Biology, having authored 34 papers that have together received 1.1k indexed citations. Recurring topics across this work include Neuroblastoma Research and Treatments (8 papers), Histone Deacetylase Inhibitors Research (5 papers), Cell death mechanisms and regulation (5 papers), Cancer, Hypoxia, and Metabolism (4 papers), Sirtuins and Resveratrol in Medicine (3 papers), Autophagy in Disease and Therapy (3 papers), Protein Degradation and Inhibitors (2 papers) and Liver physiology and pathology (2 papers). The work is most often cited by research in Geriatrics and Gerontology (101 citations), Oncology (381 citations), Cancer Research (181 citations), Molecular Biology (574 citations) and Cell Biology (104 citations). Fei Chu has collaborated with scholars based in United States, China and Taiwan. Frequent co-authors include Abdelhadi Rebbaa, Bernard L. Mirkin, Xin Zheng, Radhika Gudi, John Barkinge, Pauline M. Chou, Prasad Kanteti, Ravi Salgia, Shaker A. Mousa and Sandra Clark. Their work appears in journals such as Journal of Pediatric Surgery, Cancer Research, Journal of the American College of Surgeons, Oncogene and Angiogenesis.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.